Navigation Links
CNA Finance Initiates Research Coverage On Next Group Holdings, Inc.
Date:8/10/2017

CNA Finance Chief Research Analyst, Kenny Soulstring, today announced that the stock market news outlet had initiated coverage on Next Group Holdings, Inc. and see's significant opportunity in the company's plans to target the rapidly growing and underserved consumer markets geared toward those that cannot engage in traditional banking services. According to industry estimates, approximately 103 million people do not get offered a comprehensive package of financial services, requiring a large subset of consumers to look to non-conforming and potentially predatory financial alternatives. Soulstring believes that if Next Group can integrate seamlessly into the "cash-to-card" market that they can benefit from an estimated $30 billion opportunity between the United States and Mexico alone.

"It's all about staying within the strategic vision," said Soulstring. "If Next Group Holdings, Inc. can perpetuate its strategy and remain laser focused on its primary objective and opportunity, the company may become a significant and profitable niche player".

To become successful, though, Soulstring believes that the company must execute upon its plan strategically and deliver on its mission to become a 24/7/365 virtual bank geared toward the nations underserved population. Next Group believes that its CUENTAS platform can simplify and facilitate transactions for a targeted population of users which may lead to an expansion of a robust market opportunity which is currently estimated to be a $30 billion market potential.

According to Kenny Soulstring,"With the company's launch of CUENTAS, Next Group may quickly position themselves to become a reliable niche player in a vast and relatively untapped market. Already serving the needs of consumers by offering discount and loyalty programs, CUENTAS is positioning itself to deliver accretive growth through a plan of targeted marketing and cooperative promotional efforts".

Noting the financials, Next Group, Inc. recently posted record earnings of .03 cents per fully diluted share during the first quarter of the fiscal year 2017. Soulstring believes that an opportunity exists for investors willing to take a position into a high risk, high reward investment. Although Next Group Holdings, Inc. trades at a micro-valued price level, the potential for the stock price to rise in conjunction with the continued execution of the CUENTAS roll-out may drive incremental share price growth during the next several quarters.

To read Kenny Soulstring's complete research report on Next Group Holdings, Inc., click here.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14586250.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. GlycoVaxyn AG secures CHF 5.1 million Strategic Translation Award from the Wellcome Trust to finance clinical development of Shigella vaccine
2. Benu BioVentures to Finance Early Biopharmaceutical Clinical Development
3. Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer
4. ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
5. iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare
6. Neurotez Engages Invictus Global Capital as Corporate Finance & Capital Markets Advisors
7. Revenue Leak Soon Turns to Flood: Payment Penalties for High Infection Rates Draining Hospital Finances
8. Yew Bio-Pharm Group Signs Sales Agreement and Receives Subsidy Grant from the Finance Department of Heilongjiang Province, China
9. Oxford Finance Closes $20 Million Debt Facility with Inhibrx
10. Oxford Finance Provides $10 Million Debt Financing to Celula
11. CSM Appoints Michael Morse as Vice President of Finance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree Wellness ... targeting the needs of consumers who are incorporating medical marijuana into their wellness ... Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s two ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first ... accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):